Isotype modulates epitope specificity, affinity, and antiviral activities of anti–HIV-1 human broadly neutralizing 2F5 antibody
Daniela Tudor(Délégation Paris 5), Morgane Bomsel(Centre National de la Recherche Scientifique), Tahar Bouceba(Sorbonne Université), Julien Maupetit(Délégation Paris 7), Isabelle Schwartz-Cornil(Institut National de la Recherche Agronomique), Huifeng Yu(Centre National de la Recherche Scientifique), Lucia Lopalco(Vita-Salute San Raffaele University), Anne-Sophie Drillet(Délégation Paris 5), Pierre Tufféry(Centre National de la Recherche Scientifique)
Cited by 135
Related Papers
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
|PubMed|1991|247
Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells
|The Journal of Immunology|2000|244